Frédéric Bigot

903 citations
46 papers · 535 · h-index 10

Impact in

  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Inflammatory Biomarkers in Disease Prognosis
    • Cancer Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
    • Renal cell carcinoma treatment
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Cancer Immunotherapy and Biomarkers 8
    • COVID-19 and healthcare impacts 6
    • Cancer Diagnosis and Treatment 5
    • PARP inhibition in cancer therapy 3
    • Lung Cancer Treatments and Mutations 7
    • Lung Cancer Diagnosis and Treatment 6

Frédéric Bigot

39 papers receiving 520 citations

Peers

Frédéric Bigot
Comparison fields: 5 of 49
  • Oncology 236
  • Pulmonary and Respiratory Medicine 145
  • Cancer Research 33
  • Hepatology 13
  • Surgery 60
Replace Shalmali Bane with:
Shalmali Bane United States
Qiaofeng Zhong China
Richard A. Burkhart United States
Çağlayan Geredeli Türkiye
Hiroshi Sonoue Japan
Christos G. Katsios Greece
Lene Weber Vestermark Denmark
Cynthia M. Yoshida United States
Jean‐Charles Goeminne Belgium
Issam Abd Alsamad France
Frédéric Bigot relative to Shalmali Bane United States Shalmali Bane's profile →
Citations per field
00.5×5×10×14.5×
Shalmali Bane · 1×
Citations per year

Countries citing papers authored by Frédéric Bigot

Since Specialization
Citations

This map shows the geographic impact of Frédéric Bigot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Bigot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Bigot more than expected).

Fields of papers citing papers by Frédéric Bigot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Bigot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Bigot. The network helps show where Frédéric Bigot may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Bigot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Bigot Line = papers co-authored together Frédéric Bigot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2017174
2 201151
3 201349
4 202246
5 202437
6 201621
7 200916
8 202312
9 202512
10 201811
11 201710
12 202110
13 202310
14 20249
15 20208
16 20216
17 20256
18 20245
19 20234
20 20173

About Frédéric Bigot

Frédéric Bigot is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology, Infectious Diseases and Cancer Research, having authored 46 papers that have together received 535 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), COVID-19 and healthcare impacts (6 papers), Cancer Diagnosis and Treatment (5 papers), Endometrial and Cervical Cancer Treatments (3 papers), PARP inhibition in cancer therapy (3 papers) and Cervical Cancer and HPV Research (2 papers). The work is most often cited by research in Oncology (236 citations), Pulmonary and Respiratory Medicine (145 citations), Cancer Research (33 citations), Hepatology (13 citations) and Surgery (60 citations). Frédéric Bigot has collaborated with scholars based in France, Spain and Italy. Frequent co-authors include Christophe Massard, Alberto Carmona‐Bayonas, Aurélien Marabelle, Sophie C. Postel-Vinay, Vincent Ribrag, Anas Gazzah, Jean‐Charles Soria, Jean‐Marie Michot, Jessica Menis and Capucine Baldini. Their work appears in journals such as Annals of Oncology, ESMO Open, Cancers, Investigational New Drugs and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact